Serum levels of tumor necrosis factor, interleukin 2 receptor, and interferon-γ in Kawasaki disease involved coronary-artery lesions
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 56 (1), 29-36
- https://doi.org/10.1016/0090-1229(90)90166-n
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in KoreaKorean Circulation Journal, 2019
- Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki diseaseClinical Immunology and Immunopathology, 1988
- Two monokines, interleukin 1 and tumor necrosis factor, render cultured vascular endothelial cells susceptible to lysis by antibodies circulating during Kawasaki syndrome.The Journal of Experimental Medicine, 1986
- Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon.Journal of Clinical Investigation, 1986
- Identity of tumour necrosis factor and the macrophage-secreted factor cachectinNature, 1985
- T cell growth factor receptors. Quantitation, specificity, and biological relevanceThe Journal of Experimental Medicine, 1981
- T‐Cell Growth FactorImmunological Reviews, 1980
- Pathology of the Heart in Kawasaki DiseasePediatrics, 1978
- Morphological observations on the vasculitis in the mucocutaneous lymph node syndromeEuropean Journal of Pediatrics, 1978
- Interferon-Like Virus-Inhibitor Induced in Human Leukocytes by PhytohemagglutininScience, 1965